Medicare Enrolled

Dr. Jevon Tang, MD

Infectious Disease · Fremont, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2557 MOWRY AVE STE 12, Fremont, CA 94538
5102481550
In practice since 2007 (18 years)
NPI: 1619179504 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tang

Dr. Jevon Tang is an infectious disease specialist in Fremont, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tang performed 1,695 Medicare services across 660 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tang received a total of $14,167 from 43 pharmaceutical and/or device companies across 184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 23% volume in CA $14,167 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,695
Medicare services
Top 23% in CA for infectious disease
660
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
853 $103 $268
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
394 $70 $182
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
220 $146 $457
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $113 $317
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
25 $155 $380
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $147 $427
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $65 $240
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
16 $72 $120
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
16 $37 $53
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
11 $96 $316
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,167
Total received (2018-2024)
Avg $2,024/year across 7 years
Top 13% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
184
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,167 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$129
2023
$423
2022
$925
2021
$1,352
2020
$1,353
2019
$4,690
2018
$5,295

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$47
La Jolla Pharmaceutical Company
$42
Melinta Therapeutics, LLC
$40
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,326
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,304
AbbVie, Inc.
$1,146
AstraZeneca Pharmaceuticals LP
$922
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$909
Gilead Sciences, Inc.
$699
GlaxoSmithKline, LLC.
$588
Janssen Products, LP
$504
AbbVie Inc.
$459
Allergan, Inc.
$446
Merck Sharp & Dohme Corporation
$436
Electromed, Inc.
$416
Amgen Inc.
$391
Janssen Biotech, Inc.
$385
SANOFI-AVENTIS U.S. LLC
$349
Teva Pharmaceuticals USA, Inc.
$314
Novo Nordisk Inc
$272
PFIZER INC.
$268
Alexion Pharmaceuticals, Inc.
$247
Paratek Pharmaceuticals, Inc.
$232
EMD Serono, Inc.
$205
Synergy Pharmaceuticals Inc
$194
Amarin Pharma Inc.
$180
Relypsa, Inc.
$165
Akcea Therapeutics, Inc.
$125
IBSA Pharma Inc.
$125
Pfizer Inc.
$123
Otsuka America Pharmaceutical, Inc.
$122
Merck Sharp & Dohme LLC
$116
E.R. Squibb & Sons, L.L.C.
$114
Grifols USA, LLC
$111
ABBVIE INC.
$108
Bayer HealthCare Pharmaceuticals Inc.
$99
Astellas Pharma US Inc
$95
Takeda Pharmaceuticals U.S.A., Inc.
$94
Mallinckrodt LLC
$92
Actelion Pharmaceuticals US, Inc.
$90
Genentech USA, Inc.
$84
Mallinckrodt Hospital Products Inc.
$82
Regeneron Healthcare Solutions, Inc.
$77
Sanofi Pasteur Inc.
$70
La Jolla Pharmaceutical Company
$42
Melinta Therapeutics, LLC
$40
Top 3 companies account for 26.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · ANORO · AVYCAZ · Adempas · BAVENCIO · BREZTRI · Biktarvy · CINQAIR · CRESEMBA · DALVANCE · DIFICID · DISEASE STATE · ELIQUIS · Epclusa · Esbriet · FASENRA · FLUZONE HIGH-DOSE · HyperRAB SD · INVOKANA · ISENTRESS · JARDIANCE · JYNARQUE · LOKELMA · Letairis · LifeVest · MAVYRET · Mavyret · NUCALA · NUZYRA · OFEV · Ozempic · PIFELTRO · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREZCOBIX · QVAR · RYBELSUS · Repatha · Rezzayo · SMARTVEST · SOLIQUA · SOLIRIS · STEGLATRO · STELARA · SYMTUZA · Symtuza · TEFLARO · TEGSEDI · TOUJEO · TRELEGY ELLIPTA · Tirosint · Trulance · VYNDAQEL · Vascepa · Veltassa · Vemlidy · XARELTO · XERAVA · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Fremont?
Compare infectious diseases in the Fremont area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
95
Per 100K population
5.8
County median income
$126,240
Nearest hospital
WASHINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tang is a mixed practice specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tang experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Tang performed 853 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tang receive payments from pharmaceutical companies?
Yes. Dr. Tang received a total of $14,167 from 43 companies across 184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tang's costs compare to other infectious diseases in Fremont?
Dr. Tang's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →